相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Phase I/II trial of erlotinib and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: A Princess Margaret Hospital Phase II Consortium and National Cancer Institute of Canada Clinical Trials Group study
Lillian L. Siu et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Loss of p53 expression correlates with metastatic phenotype and transcriptional profile in a new mouse model of head and neck cancer
Tony K. S. Ku et al.
MOLECULAR CANCER RESEARCH (2007)
Postoperative chemoradiotherapy for advanced squamous cell carcinoma of the head and neck: A systematic review with meta-analysis
Eric Winquist et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2007)
Adenoviral gene therapy in head and neck cancer
Emanuela Vattemi et al.
DRUG NEWS & PERSPECTIVES (2006)
Improved efficacy of DNA vaccination against breast cancer by boosting with the repeat beta-hCG C-terminal peptide carried by mycobacterial heat-shock protein HSP65
Y He et al.
VACCINE (2006)
DNA vaccines for therapy of tuberculosis: Where are we now?
DB Lowrie
VACCINE (2006)
Heat shock proteins as vaccine adjuvants in infections and cancer
Brahm H. Segal et al.
DRUG DISCOVERY TODAY (2006)
Rifapentine, moxifloxacin, or DNA vaccine improves treatment of latent tuberculosis in a mouse model
E Nuermberger et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Validation overview of bio-analytical methods
M Tuomela et al.
GENE THERAPY (2005)
Peptides chaperoned by heat-shock proteins are a necessary and sufficient source of antigen in the cross-priming of CD8+ T cells
RJ Binder et al.
NATURE IMMUNOLOGY (2005)
Immunotherapy with plasmid DNA encoding mycobacterial hsp65 in association with chemotherapy is a more rapid and efficient form of treatment for tuberculosis in mice
CL Silva et al.
GENE THERAPY (2005)
Heat shock proteins: biological functions and clinical application as personalized vaccines for human cancer
C Castelli et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Immune regulatory effect of pHSP65 DNA therapy in pulmonary tuberculosis:: activation of CD8+ cells, interferon-γ recovery and reduction of lung injury
VLD Bonato et al.
IMMUNOLOGY (2004)
Efficacy of DNA-hsp65 vaccination for tuberculosis varies with method of DNA introduction in vivo
KM Lima et al.
VACCINE (2003)
The group II chaperonin TRiC protects proteolytic intermediates from degradation in the MHC class I antigen processing pathway
J Kunisawa et al.
MOLECULAR CELL (2003)
A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition
J Michaëlsson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Tumor cell membrane-bound heat shock protein 70 elicits antitumor immunity
XH Chen et al.
IMMUNOLOGY LETTERS (2002)
The Mycobacterium leprae hsp65 displays proteolytic activity.: Mutagenesis studies indicate that the M-leprae hsp65 proteolytic activity is catalytically related to the Hs1VU protease
FCV Portaro et al.
BIOCHEMISTRY (2002)
Phase II and biologic study of interferon alfa, retinoic acid, and cisplatin in advanced squamous skin cancer
DM Shin et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Roles of heat-shock proteins in innate and adaptive immunity
P Srivastava
NATURE REVIEWS IMMUNOLOGY (2002)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
Naked DNA and adenoviral immunizations for immunotherapy of prostate cancer: A phase I/II clinical trial
M Mincheff et al.
EUROPEAN UROLOGY (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
